Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 13;17(10):e0276064.
doi: 10.1371/journal.pone.0276064. eCollection 2022.

Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates

Affiliations

Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates

Noor Ulain et al. PLoS One. .

Abstract

Background: Extra pulmonary tuberculosis (EPTB) constitutes 18% of all tuberculosis (TB) cases and tuberculous lymphadenitis (TBL) constitutes 20-40% of EPTB. Diagnosis of TBL is challenging because of the paucibacillary nature of the disease.

Objective: To investigate the diagnostic potential of a new antigen detection test based on the detection of M. tuberculosis complex specific antigen MPT64 from fine needle aspirate (FNA) cytology smears and biopsies obtained from patients with clinically suspected TBL using immunohistochemistry (IHC).

Materials and methods: This study was conducted at Khyber Teaching Hospital and Rehman Medical Institute, Peshawar, Pakistan, from January 2018 to April 2019. Samples, including FNA (n = 100) and biopsies (n = 8), were collected from 100 patients with presumptive TBL. Direct smears and cell blocks were prepared from the FNA samples. All samples were subjected to hematoxylin-eosin (H&E) staining, Ziehl-Neelsen (ZN) staining, and immunostaining with polyclonal anti-MPT64 antibody. The culture was performed only for biopsy specimens. All patients were followed until the completion of anti-TB treatment. The response to treatment was included in the composite reference standard (CRS) and used as the gold standard to validate the diagnostic tests.

Results: The sensitivity, specificity, positive and negative predictive values for ZN staining were 4.4%,100%,100%,56%, for culture were 66%,100%,100%,50%, for cytomorphology were 100%,90.91%,90%,100%, and for immunostaining with anti-MPT64 were all 100%,respectively. The morphology and performance of immunohistochemistry were better with cell blocks than with smears.

Conclusion: MPT64 antigen detection test performed better than ZN and cytomorphology in diagnosing TBL. This test applied to cell blocks from FNA is robust, simple, and relatively rapid, and improves the diagnosis of TBL.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Study design, follow-up, and patient categorization into TB and non-TB cases.
Abbreviations: EPTB, extrapulmonary tuberculosis; TB, tuberculosis; ESR, erythrocyte sedimentation rate; FNA, fine-needle aspirates; TB ICT, immunochromatographic test for tuberculosis; AFB, acid-fast bacilli.
Fig 2
Fig 2
Hematoxylin & Eosin staining pattern in a tuberculous lymphadenitis case in a cell block (A,B) and a biopsy section (C,D). (A)10x, (B) 40x showing epithelioid cells (white arrow) and lymphocytes (blue arrow). (C) 10x, (D) 40x, showing epithelioid cells (white arrow), multinucleated giant cells (black arrow), and lymphocytes (blue arrow).
Fig 3
Fig 3
Immunohistochemical staining of cell block sections (A, B, C), and biopsy sections (D,E,F) by anti-MPT64 antibodies. A-C; Cytoplasmic staining of MPT64 in epithelioid cells (blue arrow), multinucleated giant cells (black arrow), and macrophages (white arrow). D-F; Cytoplasmic staining of MPT64 in epithelioid cells (blue arrow), macrophages (white arrow), and multinucleated giant cells (black arrow).

References

    1. World Health Organization (WHO). Global tuberculosis report 2021;2021: Accessed on: 5th January 2022. Available from: https://apps.who.int/iris/rest/bitstreams/1379788/retrieve.
    1. Tahseen S, Khanzada FM, Baloch AQ, Abbas Q, Bhutto MM, Alizai AW, et al.. Extrapulmonary tuberculosis in Pakistan-A nation-wide multicenter retrospective study.PLoS One 2020;15(4):e0232134. doi: 10.1371/journal.pone.0232134 - DOI - PMC - PubMed
    1. Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul) 2015;78(2):47–55. doi: 10.4046/trd.2015.78.2.47 - DOI - PMC - PubMed
    1. Tadele A, Beyene D, Hussein J, Gemechu T, Birhanu A, Mustafa T, et al.. Immunocytochemical detection of Mycobacterium Tuberculosis complex specific antigen, MPT64, improves diagnosis of tuberculous lymphadenitis and tuberculous pleuritis. BMC Infect Dis 2014;14(1):585. doi: 10.1186/s12879-014-0585-1 - DOI - PMC - PubMed
    1. Jha B, Dass A, Nagarkar N, Gupta R, Singhal S. Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J 2001;77(905):185–7. doi: 10.1136/pmj.77.905.185 - DOI - PMC - PubMed

Publication types